Patrick Rensen/LinkedIn
Nov 7, 2025, 03:26
Patrick Rensen: A Press Release of Monash University Related to Our Recent Publication in Science Advances
Patrick Rensen, Professor at Leiden University Medical Center, posted on LinkedIn:
“A press release of Monash University related to our recent publication in Science Advances on the dual beneficial action of the experimental drug IC7Fc in insulinresistance and atherosclerosis, revealing potential ‘two-in-one’ treatment for T2D and ASCVD!”
Read full study here.
Stay informed with Hemostasis Today.
-
Oct 14, 2026, 07:36Daniel Pereira Monteiro: ASCAT 2026 A Day of Science, Connection and Community
-
Oct 14, 2026, 07:20Rachael Jackman: Understanding Models of Transfusion Medicine at AABB 2026
-
Oct 14, 2026, 07:09Dianne E. van der Wal: A New Chapter in Academia Celebrating a Journey in Research, Teaching and Platelet Science
-
Oct 14, 2026, 06:55Mahdieh Dagina Pedersen: A Meaningful Milestone in Hemophilia A Research and Oral Drug Development
-
Oct 14, 2026, 06:37Neoklis Mparis: Unilateral Adrenal Haemorrhage in Primary Antiphospholipid Syndrome During Bridging Anticoagulation
-
Oct 14, 2026, 06:00Aymen A.: LAAC vs. OAC in Patients with Atrial Fibrillation Including CHAMPION-AF and CLOSURE-AF Trials
-
Oct 13, 2026, 21:05Francisco Chacón-Lozsán: Heparin-Induced Thrombocytopenia – When an Anticoagulant Triggers Thrombosis
-
Oct 13, 2026, 21:04Aref Zribi: Isolated Tumor Thrombus and the Role of Prophylactic Anticoagulation
-
Oct 13, 2026, 21:01Alex Larson: Why Normal Bloodwork Does Not Always Tell the Whole Story